Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study

References

• Wang H, Naghavi M, Allen C, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–1544.
   PubMed Web of Science ®Google Scholar
• Almagro P, Boixeda R, Diez-Manglano J, Gómez-Antúnez M, López-García F, Recio J. Insights into chronic obstructive pulmonary disease as critical risk factor for cardiovascular disease. Int J Chron Obstruct Pulmon Dis. 2020;15:755–764. doi:10.2147/COPD.S238214
   PubMed Web of Science ®Google Scholar
• Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631–639.
   PubMed Web of Science ®Google Scholar
• Putcha N, Drummond MB, Wise RA, Hansel NN. Comorbidities and chronic obstructive pulmonary disease: prevalence, influence on outcomes, and management. Semin Respir Crit Care Med. 2015;36(4):575–591.
   PubMed Web of Science ®Google Scholar
• Müllerova H, Agusti A, Erqou S, Mapel DW. Cardiovascular comorbidity in COPD: systematic literature review. Chest. 2013;144(4):1163–1178.
   PubMed Web of Science ®Google Scholar
• Mapel DW, Dedrick D, Davis K. Trends and cardiovascular comorbidities of COPD patients in the veterans administration medical system, 1991–1999. COPD. 2005;2:35–41.
   PubMedGoogle Scholar
• Anthonisen NR, Connett JE, Enright PL, Manfreda J. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med. 2002;166:333–339.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Skeans M, Wise R, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality. Ann Intern Med. 2005;142(4):233–239.
   PubMed Web of Science ®Google Scholar
• McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax. 2007;62(5):411–415.
   PubMed Web of Science ®Google Scholar
• Donaldson G, Hubbard R, Wedzicha JA. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010;137(5):1091–1097. doi:10.1378/chest.09-2029
   PubMed Web of Science ®Google Scholar
• Almagro P, Soriano JB. Underdiagnosis in COPD: a battle worth fighting. Lancet Respir Med. 2017;5(5):5. doi:10.1016/S2213-2600(17)30133-9
   PubMed Web of Science ®Google Scholar
• Bundhun PK, Gupta C, Xu GM. Major adverse cardiac events and mortality in chronic obstructive pulmonary disease following percutaneous coronary intervention: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2017;17(1):1–13. doi:10.1186/s12872-017-0622-2
   PubMed Web of Science ®Google Scholar
• Mooe T, Stenfors N. The prevalence of COPD in individuals with acute coronary syndrome: a spirometry-based screening study. COPD. 2014;2555:1–9.
   Google Scholar
• Franssen FME, Soriano JB, Roche N, et al. Lung function abnormalities in smokers with ischemic heart disease. Am J Respir Crit Care Med. 2016;194(5):568–576. doi:10.1164/rccm.201512-2480OC
   PubMed Web of Science ®Google Scholar
• Almagro P, Lapuente A, Pareja J, et al. Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study. Int J Chron Obstruct Pulmon Dis. 2015;10:43.
   Web of Science ®Google Scholar
• Soriano JB, Rigo F, Guerrero D, et al. High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease. Chest. 2010;137(2):333–340. doi:10.1378/chest.09-1264
   PubMed Web of Science ®Google Scholar
• Almagro P, De la Sierra A, Acosta E, et al. Spirometrically confirmed chronic obstructive pulmonary disease worsens long-term prognosis after percutaneous coronary intervention. Am J Respir Crit Care Med. 2018;197(6):824. doi:10.1164/rccm.201707-1389LE
   PubMed Web of Science ®Google Scholar
• Regan EA, Lynch DA, Curran-Everett D, et al. Clinical and radiologic disease in smokers with normal spirometry. JAMA Intern Med. 2015;175(9):1539–1549. doi:10.1001/jamainternmed.2015.2735
   PubMed Web of Science ®Google Scholar
• Woodruff PG, Barr RG, Bleecker E, et al. Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med. 2016;374(19):1811–1821. doi:10.1056/NEJMoa1505971
   PubMed Web of Science ®Google Scholar
• Ramalho SHR, Shah AM. Lung function and cardiovascular disease: a link. Trends Cardiovasc Med. 2021;31(2):93–98. doi:10.1016/j.tcm.2019.12.009
   PubMed Web of Science ®Google Scholar
• Cheng Y-J, Chen Z-G, Li Z-Y, Mei W-Y, Bi W-T, Luo D-L. Longitudinal change in lung function and subsequent risks of cardiovascular events: evidence from four prospective cohort studies. BMC Med. 2021;19(1):1. doi:10.1186/s12916-021-02023-3
   PubMed Web of Science ®Google Scholar
• Agustí A, Noell GM, Brugada J, et al. Lung function in early adulthood and health in later life: a transgenerational cohort analysis. Lancet Respir Med. 2017;5(12):935–945. doi:10.1016/S2213-2600(17)30434-4
   PubMed Web of Science ®Google Scholar
• Celli BR, Wedzicha JA. Update on clinical aspects of chronic obstructive pulmonary disease. N Engl J Med. 2019;381(13):1257–1266.
   PubMed Web of Science ®Google Scholar
• Emerging risk factors collaboration. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012;367(14):1310–1320.
   PubMed Web of Science ®Google Scholar
• Celli BR, Locantore N, Yates J, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(10):1065–1072.
   PubMed Web of Science ®Google Scholar
• Ben-Shlomo Y, Spears M, Boustred C, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol. 2014;63(7):636–646.
   PubMed Web of Science ®Google Scholar
• Fisk M, McEniery CM, Gale N, et al. Surrogate markers of cardiovascular risk and chronic obstructive pulmonary disease. Hypertension. 2018;71(3):499–506.
   PubMed Web of Science ®Google Scholar
• Crim C, Anderson JA, Calverley PMA, et al. Pulse wave velocity in chronic obstructive pulmonary disease and the impact of inhaled therapy (SUMMIT): a randomized double-blind clinical trial. Am J Respir Crit Care Med. 2020;201(10):1307–1310.
   PubMed Web of Science ®Google Scholar
• Kirigaya J, Iwahashi N, Takahashi H, et al. Impact of cardio-ankle vascular index on long-term outcome in patients with acute coronary syndrome. J Atheroscler Thromb. 2020;27(7):657–668.
   PubMed Web of Science ®Google Scholar
• Pavasini R, D’Ascenzo F, Campo G, et al. Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Cardiol. 2015;191:187–193.
   PubMed Web of Science ®Google Scholar
• Pavasini R, Tavazzi G, Biscaglia S, et al. Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis. Chron Respir Dis. 2017;14(2):117–126.
   PubMed Web of Science ®Google Scholar
• Hill J, Heslop C, Man SFP, et al. Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality. Eur Heart J. 2011;32(15):1918–1925.
   PubMed Web of Science ®Google Scholar
• Siasos G, Oikonomou E, Maniatis K, et al. Prognostic significance of arterial stiffness and osteoprotegerin in patients with stable coronary artery disease. Eur J Clin Invest. 2018;48(3):e12890.
   Web of Science ®Google Scholar
• Patel AR, Kowlessar BS, Donaldson GC, et al. Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188(9):1091–1099.
   PubMed Web of Science ®Google Scholar
• Zemans RL, Jacobson S, Keene J, et al. Multiple biomarkers predict disease severity, progression and mortality in COPD. Respir Res. 2017;18(1):117.
   PubMed Web of Science ®Google Scholar
• Serban KA, Pratte KA, Bowler RP. Protein biomarkers for COPD outcomes. Chest. 2021;159(6):2244–2253.
   PubMed Web of Science ®Google Scholar
• Coluccia V, Burzotta F, Romagnoli E, et al. EuroSCORE predicts long-term mortality of unselected patients undergoing percutaneous coronary interventions. Int J Cardiol. 2013;167(4):1232–1236.
   PubMed Web of Science ®Google Scholar
• Fox KA, FitzGerald G, Puymirat E, et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ Open. 2014;4(2):e004425.
   PubMed Web of Science ®Google Scholar
• Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219–227.
   PubMedGoogle Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Butlin M, Qasem A. Large artery stiffness assessment using SphygmoCor technology. Pulse. 2016;4(4):180–192.
   PubMedGoogle Scholar
• Matsushita K, Ding N, ED Kim, et al. Cardio-ankle vascular index and cardiovascular disease: systematic review and meta-analysis of prospective and cross-sectional studies. J Clin Hypertens. 2019;21(1):16–24.
   Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardization of spirometry. Eur Respir J. 2005;26(2):319–338.
   PubMed Web of Science ®Google Scholar
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary diseases (2022 report). Global initiative for chronic obstructive Pulmonary Disease (GOLD). Available from: https://goldcopd.org/2022-gold-reports-2/. Accessed May 1, 2022.
   Google Scholar
• Khassawneh BY, Samrah SM, Jarrah MI, et al. Prevalence of undiagnosed COPD in male patients with coronary artery disease: a cross-sectional study in Jordan. Int J Chron Obstruct Pulmon Dis. 2018;13:2759–2766.
   PubMed Web of Science ®Google Scholar
• Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis. 2009;4:337–349.
   PubMedGoogle Scholar
• Vivodtzev I, Tamisier R, Baguet JP, Borel JC, Levy P, Pépin JL. Arterial stiffness in COPD. Chest. 2014;145(4):861–875. doi:10.1378/chest.13-1809
   PubMed Web of Science ®Google Scholar
• Zaigham S, Östgren CJ, Persson M, et al. The association between carotid-femoral pulse-wave velocity and lung function in the Swedish CArdioPulmonary bioImage study (SCAPIS) cohort. Respir Med. 2021;185:106504.
   PubMed Web of Science ®Google Scholar
• Fang Y, Zhong Q. Investigation of the value of carotid-femoral pulse wave velocity and coronary artery lesions in prognosis of percutaneous coronary intervention patients. Am J Transl Res. 2021;13(6):6646.
   PubMed Web of Science ®Google Scholar
• Chen BW, Wang ZG, Liu Q, Wang X, Dang A. Combination of pulse wave velocity with clinical factors as a promising tool to predict major adverse cardiac events after percutaneous coronary intervention. J Cardiol. 2015;65(4):318–323.
   PubMed Web of Science ®Google Scholar
• Park HW, Kang MG, Kim K, et al. Prognostic value of brachial-ankle pulse wave velocity in patients with non-ST-elevation myocardial infarction. Coron Artery Dis. 2017;28(8):642–648.
   PubMed Web of Science ®Google Scholar
• Lechner I, Reindl M, Tiller C, et al. Determinants and prognostic relevance of aortic stiffness in patients with recent ST-elevation myocardial infarction. Int J Cardiovasc Imaging. 2022;38(1):237–247.
   PubMed Web of Science ®Google Scholar
• Feistritzer HJ, Klug G, Reinstadler SJ, et al. Prognostic value of aortic stiffness in patients after ST-elevation myocardial infarction. J Am Heart Assoc. 2017;6:9.
   Web of Science ®Google Scholar
• Prskalo Z, Brizić I, Markota D, et al. Arterial stiffness in patients with coronary artery disease: relation with in-stent restenosis following percutaneous coronary intervention. BMC Cardiovasc Disord. 2016;16:1. doi:10.1186/S12872-016-0305-4
   PubMed Web of Science ®Google Scholar
• Aimo A, Georgiopoulos G, Panichella G, et al. High-sensitivity troponins for outcome prediction in the general population: a systematic review and meta-analysis. Eur J Intern Med. 2022;98:61–68.
   PubMed Web of Science ®Google Scholar
• Adamson PD, Anderson JA, Brook RD, et al. Cardiac troponin I and cardiovascular risk in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol. 2018;72(10):1126–1137.
   PubMed Web of Science ®Google Scholar
• Pizarro C, Herweg-Steffens N, Buchenroth M, et al. Invasive coronary angiography in patients with acute exacerbated COPD and elevated plasma troponin. Int J Chron Obstruct Pulmon Dis. 2016;11:2081–2089.
   PubMedGoogle Scholar
• Nandy D, Sharma N, Senapati S. Systematic review and meta-analysis confirms significant contribution of surfactant protein D in chronic obstructive pulmonary disease. Front Genet. 2019;10:339.
   PubMed Web of Science ®Google Scholar
• Labonté LE, Bourbeau J, Daskalopoulou SS, et al. Club Cell-16 and RelB as novel determinants of arterial stiffness in exacerbating COPD patients. PLoS One. 2016;11(2):e0149974.
   PubMed Web of Science ®Google Scholar
• Carrero JJ, Andersson Franko M, Obergfell A, Gabrielsen A, Jernberg T. hsCRP level and the risk of death or recurrent cardiovascular events in patients with myocardial infarction: a healthcare-based study. J Am Heart Assoc. 2019;8(11):e012638.
   PubMed Web of Science ®Google Scholar
• Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 1993;118:956–963.
   PubMed Web of Science ®Google Scholar
• Jackson J, Alkhalil M, Ratcovich H, Wilkinson C, Mehran R, Kunadian V. Evidence base for the management of women with non-ST elevation acute coronary syndrome. Heart. 2022:3:34.
   Google Scholar
• Khan E, Brieger D, Amerena J, et al. Differences in management and outcomes for men and women with ST-elevation myocardial infarction. Med J Aust. 2018;209(3):118–123.
   PubMed Web of Science ®Google Scholar